Memphis Defense Depot
Base Background
Location
2028, Memphis Depot Parkway, Memphis, Tennessee, 38114, United States
Years of Operation
1942-1997
The Memphis Defense Depot opened in 1942 as a logistical support facility for the military during World War II. This site was also a storage facility for hazardous materials. The EPA placed the site on the National Priorities List during the 90’s, and the depot officially closed in 1997. It was then converted into the Memphis Depot Industrial Park, which recently sold.
Known Toxins
The following chart outlines the toxins associated with this military location and the potential effects of exposure.*
| Toxin | Potential Effects | |||
|---|---|---|---|---|
| Strong | Good | Limited | ||
| Arsenic | Potential Effects | Peripheral neuropathy, Hyperkeratosis/Hyperpigmentation, Diabetes Type II, Coronary artery disease, peripheral vascular disease, atherosclerosis | Steatosis (fatty liver), Skeletal malformations, Renal (kidney) cancer, Raynaud's phenomenon, Pneumonitis hypersensitivity, Neural tube defects/CNS malformations, Nasal septal perforation, Myocardial ischemia, Low birth weight/Small for Gestational Age, Hypertension, Hepatoportal Sclerosis, Fetotoxicity (Miscarriage/spontaneous abortion; stillbirth), Congenital malformations general, Cirrhosis, Cardiomyopathy, Bladder cancer, Arrhythmias, Anemia hemolytic, Alopecia, Adult-Onset Leukemias | Neurosthenia (Organic affective syndrome), Myelodysplastic syndrome, Metal fume fever, Immune suppression, Hepatocellular cancer (Liver cancer), Genitourinary malformations (includes cryptorchidism, hypospadias), Cognitive impairment (includes impaired learning, impaired memory, and decreased attention span), Acute tubular necrosis |
| Dieldrin | Potential Effects | - | Hormonal changes (levels of circulating sex hormones FSH/LH, Inhibin, and/or estrogens, progesterones, and androgens) | Uterine cancer, Thrombocytopenia, Psychiatric disturbances, Parkinson's disease/Movement disorders, Lymphoma non Hodgkin's, Hormonal changes (levels of circulating sex hormones FSH/LH, Inhibin, and/or estrogens, progesterones, and androgens), Colorectal cancer, Cognitive impairment (includes impaired learning, impaired memory, and decreased attention span), Breast cancer, Adult-Onset Leukemias |
| Perchloroethylene (PCE) | Potential Effects | - | - | - |
| Polychlorinated Byphenyls (PCBs) | Potential Effects | Thyroid disorders Hypothyroidism, Porphyria toxic, Developmental Delay, Decreased I.Q../Mental retardation, Cirrhosis, Chloracne, Behavioral problems, ADD/ADHD, hyperactivity | Peripheral neuropathy, Pancreatic cancer, Menstrual disorders, Lymphoma non Hodgkin's, Low birth weight/Small for Gestational Age, Immune suppression, Hepatocellular cancer (Liver cancer), Dyslipidemia, hypercholesterolemia, Delayed growth, Congenital malformation Cranio Facial, Cognitive impairment (includes impaired learning, impaired memory, and decreased attention span), Bronchitis chronic, Acute hepatocellular injury (Hepatitis), Abnormal sperm (morphology, motility, and sperm count) | Testicular cancer, Reduced Fertility Female (infertility and subfertility), Parkinson's disease/Movement disorders, Hypoactivity, Hypertension, Hyperkeratosis/Hyperpigmentation, Hearing loss, Endometriosis, Diabetes Type I, Breast cancer, Bone cancer/Ewings sarcoma, Altered time to sexual maturation (accelerated or delayed puberty), Altered sex ratio |
| Polynuclear Aromatic Hydrocarbons (PAHs) | Potential Effects | Scrotal cancer, Porphyria toxic, Laryngeal cancer | Skin cancer (nonmelanoma), Renal (kidney) cancer, Prostate cancer, Photosensitivity, Pancreatic cancer, Nasopharyngeal/SinoNasal cancer, Lung cancer, Immune suppression, Esophageal cancer, Breast cancer, Bladder cancer | Reduced Fertility Male (infertility and subfertility), Oral cancer, Melanoma, Early onset menopause, Coronary artery disease, peripheral vascular disease, atherosclerosis, Colorectal cancer, Bone cancer/Ewings sarcoma, Adult-Onset Leukemias |
| Trichloroethylene (TCE) | Potential Effects | Acute hepatocellular injury (Hepatitis) | Scleroderma, Renal (kidney) cancer, Psychiatric disturbances, Lymphoma non Hodgkin's, Hepatocellular cancer (Liver cancer), Fetotoxicity (Miscarriage/spontaneous abortion; stillbirth), Decreased Coordination/ Dysequilibrium, Cirrhosis, Childhood Leukemias, Cardiac congenital malformations, Autoimmune antibodies, positive ANA, Arrhythmias | Trigeminal neuropathy, Testicular cancer, Systemic Lupus Erythematosus, Raynaud's phenomenon, Prostate cancer, Peripheral neuropathy, Pancreatitis, Pancreatic cancer, Oral clefts (cleft lip and palate), Neural tube defects/CNS malformations, Nephrotic syndrome, Multiple myeloma, Lung cancer, Low birth weight/Small for Gestational Age, Immune suppression, Hodgkin's Disease (lymphoma), Genitourinary malformations (includes cryptorchidism, hypospadias), Cognitive impairment (includes impaired learning, impaired memory, and decreased attention span), Choanal atresia, Cervical cancer, Brain cancer adult, Adult-Onset Leukemias, ADD/ADHD, hyperactivity, Acute tubular necrosis |
If you were stationed at Memphis Defense Depot and later experienced adverse health effects, you may be eligible for compensation.
*Effects are according to the Center for Disease Control and Prevention’s Agency for Toxic Substances & Disease Registry unless otherwise noted.